Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations.

Dumbrava, E Ileana; Brusco, L; Daniels, M; Wathoo, C; Shaw, K; Lu, K; Zheng, X; Strong, L; Litton, J; Arun, B; Eterovic, A K; Routbort, M; Patel, K; Qi, Yuan; Piha-Paul, S; Subbiah, V; Hong, D; Rodon, J; Kopetz, S; Mendelsohn, J; Mills, G B; Chen, K; Meric-Bernstam, F

Dumbrava, E Ileana; Brusco, L; Daniels, M; Wathoo, C; Shaw, K; Lu, K; Zheng, X; Strong, L; Litton, J; Arun, B; Eterovic, A K; Routbort, M; Patel, K; Qi, Yuan; Piha-Paul, S; Subbiah, V; Hong, D; Rodon, J; Kopetz, S; Mendelsohn, J; Mills, G B; Chen, K; Meric-Bernstam, F.

Afiliação

Dumbrava EI; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Brusco L; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Daniels M; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wathoo C; Program of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shaw K; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lu K; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zheng X; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Strong L; Program of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Litton J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Arun B; Program of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Eterovic AK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Routbort M; Program of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Patel K; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Qi Y; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Piha-Paul S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Subbiah V; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hong D; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rodon J; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kopetz S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mendelsohn J; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mills GB; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chen K; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Meric-Bernstam F; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.